Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05241236 · ClinicalTrials.gov registry record
MRI/Ultrasound Fusion Guided Laser Ablation of Prostate Cancer
A clinical trial of Cancer of the Prostate and Neoplasms Prostate, sponsored by Urological Research Network.
- Recruiting
- Registry status
- 5,000
- Enrollment target
- 1
- Study location
NCT05241236 is a study of Cancer of the Prostate and Neoplasms Prostate that is actively recruiting participants, run by Urological Research Network. The registered enrollment target is 5,000 participants, above the 4,478-participant average among 11 other Cancer of the Prostate trials with a reported enrollment target (12% higher). The trial reports 1 study location across 1 state.
The verdict
NCT05241236, a study of Cancer of the Prostate and Neoplasms Prostate, is actively recruiting participants, sponsored by Urological Research Network.
- RECRUITING
- Registry status
- 5,000 participants
- Enrollment target
- 1
- Study location
Study Summary
This serves as a registration trial. It aims to record short, intermediate, and long-term outcomes of patients treated with targeted laser ablation of biopsy confirmed prostate cancer. Outcomes will be categorized as: 1- Procedure Related, 2- Perioperative - Adverse Events that may occur within 90 days, 3-Oncologic: Recurrence of cancer in treatment area, de-novo tumors, conversion to radical surgery, radiation or cryoablation, emergence of metastasis, 4- Functional: Sexual and Urinary function following treatment
Conditions Studied
Interventions
- DEVICE Image Fusion (MR/US) Software Registration Guided Laser Ablation of Prostate Cancer
Study Locations (1)
Florida
- Urological Research Network - Miami Lakes
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,000 participants |
| Start Date | 2020-11-15 |
| Est. Completion | 2038-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05241236
The ClinicalTrials.gov registry entry for NCT05241236 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 5,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 4,478-participant average among 11 other Cancer of the Prostate trials with a reported enrollment target (12% higher). The listed sponsor is Urological Research Network, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Cancer of the Prostate appearing as the primary indexed condition, and to 1 intervention - of which Image Fusion (MR/US) Software Registration Guided Laser Ablation of Prostate Cancer is the first listed.
NCT05241236 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT05241236 about?
NCT05241236 is a clinical study titled "MRI/Ultrasound Fusion Guided Laser Ablation of Prostate Cancer". This serves as a registration trial. It aims to record short, intermediate, and long-term outcomes of patients treated with targeted laser ablation of biopsy confirmed prostate cancer. Outcomes will be categorized as: 1- Procedure Related, 2- Perioperative - Adverse Events that may occur within 90 d...
What is the current status of trial NCT05241236?
This trial is currently recruiting. The enrollment target is 5,000 participants. The study started on 2020-11-15. Estimated completion is 2038-11.
What conditions does trial NCT05241236 study?
This clinical trial studies the following conditions: Cancer of the Prostate, Neoplasms Prostate.
What interventions are being tested in trial NCT05241236?
The interventions under investigation include: Image Fusion (MR/US) Software Registration Guided Laser Ablation of Prostate Cancer (DEVICE).
Who is sponsoring clinical trial NCT05241236?
This trial is sponsored by Urological Research Network, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05241236 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer of the Prostate
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
MRI/Ultrasound Fusion Guided Prostate Cryotherapy
RECRUITING
-
Investigation of Impact of AI on Prostate Cancer Workflow
RECRUITING · NA
-
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
RECRUITING · Phase 3
-
Impact of an Electronic Health Record Maintenance Alert on PSA Screening Rates in a 10-Hospital Integrated Health System
RECRUITING · NA
-
Proton Boost in Prostate Cancer
ACTIVE NOT RECRUITING · NA
-
Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK)
ACTIVE NOT RECRUITING · Phase 3
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.